drugset / Trial / NCT03941405
Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)
RandomizedParallel-groupOpen-labelTreatment
Summary
resolution of hyponatremia, defined as an increase in serum sodium of more than 5 mEq/L with a final value \> 130 mEq/L, maintained for at least 48 consecutive hours during the 10-day treatment period
Timeline
- Start
- 2020-02-01
- Primary completion
- 2024-12-28
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | 40 g | — |